<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1223" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1223/" /><meta name="ncbi_pagename" content="Parkinson Disease Overview - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Parkinson Disease Overview - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Parkinson Disease Overview" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2019/07/25" /><meta name="citation_author" content="Lola Cook Shukla" /><meta name="citation_author" content="Jeanine Schulze" /><meta name="citation_author" content="Janice Farlow" /><meta name="citation_author" content="Nathan D Pankratz" /><meta name="citation_author" content="Joanne Wojcieszek" /><meta name="citation_author" content="Tatiana Foroud" /><meta name="citation_pmid" content="20301402" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1223/" /><meta name="citation_keywords" content="Alpha-synuclein" /><meta name="citation_keywords" content="Cation-transporting ATPase 13A2" /><meta name="citation_keywords" content="E3 ubiquitin-protein ligase parkin" /><meta name="citation_keywords" content="F-box only protein 7" /><meta name="citation_keywords" content="Leucine-rich repeat serine/threonine-protein kinase 2" /><meta name="citation_keywords" content="Lysosomal acid glucosylceramidase" /><meta name="citation_keywords" content="Podocalyxin" /><meta name="citation_keywords" content="Protein/nucleic acid deglycase DJ-1" /><meta name="citation_keywords" content="Putative tyrosine-protein phosphatase auxilin" /><meta name="citation_keywords" content="Serine/threonine-protein kinase PINK1, mitochondrial" /><meta name="citation_keywords" content="Sodium-dependent dopamine transporter" /><meta name="citation_keywords" content="Synaptojanin-1" /><meta name="citation_keywords" content="Vacuolar protein sorting-associated protein 13C" /><meta name="citation_keywords" content="Vacuolar protein sorting-associated protein 35" /><meta name="citation_keywords" content="ATP13A2" /><meta name="citation_keywords" content="DNAJC6" /><meta name="citation_keywords" content="FBXO7" /><meta name="citation_keywords" content="GBA" /><meta name="citation_keywords" content="LRRK2" /><meta name="citation_keywords" content="PARK7" /><meta name="citation_keywords" content="PINK1" /><meta name="citation_keywords" content="PODXL" /><meta name="citation_keywords" content="PRKN" /><meta name="citation_keywords" content="SLC6A3" /><meta name="citation_keywords" content="SNCA" /><meta name="citation_keywords" content="SYNJ1" /><meta name="citation_keywords" content="VPS13C" /><meta name="citation_keywords" content="VPS35" /><meta name="citation_keywords" content="Parkinson Disease" /><meta name="citation_keywords" content="Overview" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Parkinson Disease Overview" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Lola Cook Shukla" /><meta name="DC.Contributor" content="Jeanine Schulze" /><meta name="DC.Contributor" content="Janice Farlow" /><meta name="DC.Contributor" content="Nathan D Pankratz" /><meta name="DC.Contributor" content="Joanne Wojcieszek" /><meta name="DC.Contributor" content="Tatiana Foroud" /><meta name="DC.Date" content="2019/07/25" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1223/" /><meta name="description" content="The purpose of this overview is to increase the awareness of clinicians regarding the genetics of Parkinson disease and related genetic counseling issues." /><meta name="og:title" content="Parkinson Disease Overview" /><meta name="og:type" content="book" /><meta name="og:description" content="The purpose of this overview is to increase the awareness of clinicians regarding the genetics of Parkinson disease and related genetic counseling issues." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1223/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/parkinson-overview/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1223/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE89A312E0412E910000000003AC01BB.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1223_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1223_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/jpd/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/pmld1/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1223_"><span class="title" itemprop="name">Parkinson Disease Overview</span></h1><p class="contrib-group"><span itemprop="author">Lola Cook Shukla</span>, MS, <span itemprop="author">Jeanine Schulze</span>, MS, <span itemprop="author">Janice Farlow</span>, BS, BA, <span itemprop="author">Nathan D Pankratz</span>, PhD, <span itemprop="author">Joanne Wojcieszek</span>, MD, and <span itemprop="author">Tatiana Foroud</span>, PhD.</p><a data-jig="ncbitoggler" href="#__NBK1223_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1223_ai__"><div class="contrib half_rhythm"><span itemprop="author">Lola Cook Shukla</span>, MS<div class="affiliation small">Department of Medical and Molecular Genetics<br />Indiana University School of Medicine<br />Indianapolis, Indiana<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.ui@koocpl" class="oemail">ude.ui@koocpl</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Jeanine Schulze</span>, MS<div class="affiliation small">Department of Medical and Molecular Genetics<br />Indiana University School of Medicine<br />Indianapolis, Indiana<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.ui@jezluhcs" class="oemail">ude.ui@jezluhcs</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Janice Farlow</span>, BS, BA<div class="affiliation small">Department of Medical and Molecular Genetics<br />Indiana University School of Medicine<br />Indianapolis, Indiana<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.iupui@nillj" class="oemail">ude.iupui@nillj</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Nathan D Pankratz</span>, PhD<div class="affiliation small">Minnesota Supercomputing Institute<br />University of Minnesota<br />Minneapolis, Minnesota<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.nmu@810rknap" class="oemail">ude.nmu@810rknap</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Joanne Wojcieszek</span>, MD<div class="affiliation small">Department of Neurology<br />Indiana University School of Medicine<br />Indianapolis, Indiana<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.iupui@seicjowj" class="oemail">ude.iupui@seicjowj</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Tatiana Foroud</span>, PhD<div class="affiliation small">Department of Medical and Molecular Genetics<br />Indiana University School of Medicine<br />Indianapolis, Indiana<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.ui@duoroft" class="oemail">ude.ui@duoroft</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">May 25, 2004</span>; Last Update: <span itemprop="dateModified">July 25, 2019</span>.</p><p><em>Estimated reading time: 17 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="parkinson-overview.Summary" itemprop="description"><h2 id="_parkinson-overview_Summary_">Summary</h2><p>The purpose of this overview is to increase the awareness of clinicians regarding the genetics of Parkinson disease and related <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> issues.</p><p>The following are the goals of this overview:</p><div><h4 class="inline">Goal 1.</h4><p>Describe the <a href="#parkinson-overview._escape__1_Clinical_C">clinical characteristics</a> of Parkinson disease.</p></div><div><h4 class="inline">Goal 2.</h4><p>Review the <a href="#parkinson-overview._escape__2_Causes_of">causes</a> of Parkinson disease.</p></div><div><h4 class="inline">Goal 3.</h4><p>Provide an <a href="#parkinson-overview._escape__3_Evaluation">evaluation strategy</a> to identify the genetic cause of Parkinson disease in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</p></div><div><h4 class="inline">Goal 4.</h4><p>Inform <a href="#parkinson-overview._escape__4_Genetic_Co">genetic counseling</a> for family members of an individual with Parkinson disease.</p></div><div><h4 class="inline">Goal 5.</h4><p>Provide information on <a href="#parkinson-overview._escape__5_Participat">targeted therapeutic clinical trials</a>.</p></div></div><div id="parkinson-overview._escape__1_Clinical_C"><h2 id="_parkinson-overview__escape__1_Clinical_C_">1. Clinical Characteristics of Parkinson Disease</h2><div id="parkinson-overview.Clinical_Manifestatio"><h3>Clinical Manifestations of Parkinson Disease</h3><p>Parkinson disease, a neurodegenerative disorder, is characterized by rest tremor, muscle rigidity, slowed movement (bradykinesia), and often postural instability. Onset is typically unilateral and may include other abnormal movements such as postural or action tremor as well as limb dystonia. Common associated non-motor findings include insomnia, depression, anxiety, rapid-eye-movement (REM) sleep behavior disorder, fatigue, constipation, dysautonomia, and hyposmia. As part of a prodromal phase, non-motor features may predate formal diagnosis of Parkinson disease by years. With disease progression, bilateral manifestations, balance disturbances, and other complications such as levodopa-induced dyskinesia and motor fluctuations develop. Dementia and/or psychosis occur in 30%-40%.</p><p>The diagnosis of Parkinson disease is based on the clinical findings of bradykinesia plus rest tremor and/or rigidity. An important supportive diagnostic feature is an observable response to dopaminergic therapy. Dementia is not an exclusion criterion for diagnosis. While developed for use in a genetic research study, the diagnostic criteria summarized in the following citations are increasingly being used to guide diagnosis in a clinical setting [<a class="bk_pop" href="#parkinson-overview.REF.postuma.2015.1591">Postuma et al 2015</a>, <a class="bk_pop" href="#parkinson-overview.REF.postuma.2018.1601">Postuma et al 2018</a>].</p><p>In instances of diagnostic uncertainty, especially in early stages of disease, neuroimaging such as dopamine transporter single-photon emission computed tomography (DAT-SPECT) or fluoro-dopa positron emission tomography (PET) can be used to make a more definitive diagnosis of dopaminergic deficit [<a class="bk_pop" href="#parkinson-overview.REF.ba.2015.87">Ba &#x00026; Martin 2015</a>, <a class="bk_pop" href="#parkinson-overview.REF.ibrahim.2016.102">Ibrahim et al 2016</a>]. While these studies can document the presence of dopaminergic dysfunction, they cannot distinguish between Parkinson disease and other degenerative forms of parkinsonism such as those included in Parkinson plus syndromes (see <a class="figpopup" href="/books/NBK1223/figure/parkinson-overview.F1/?report=objectonly" target="object" rid-figpopup="figparkinsonoverviewF1" rid-ob="figobparkinsonoverviewF1">Figure 1</a>). DAT-SPECT is most commonly used to distinguish Parkinson disease from essential tremor; it can also be used to verify that a symptomatic individual has a non-degenerative form of parkinsonism, such as <a href="/books/n/gene/drd/">dopa-responsive dystonia</a>. Laboratory or imaging studies such as brain MRI are useful only in excluding alternative diagnoses such as infarction, tumor, or normal-pressure hydrocephalus.</p><div class="iconblock whole_rhythm clearfix ten_col fig" id="figparkinsonoverviewF1" co-legend-rid="figlgndparkinsonoverviewF1"><a href="/books/NBK1223/figure/parkinson-overview.F1/?report=objectonly" target="object" title="Figure 1. " class="img_link icnblk_img figpopup" rid-figpopup="figparkinsonoverviewF1" rid-ob="figobparkinsonoverviewF1"><img class="small-thumb" src="/books/NBK1223/bin/parkinson-overview-Image001.gif" src-large="/books/NBK1223/bin/parkinson-overview-Image001.jpg" alt="Figure 1. " /></a><div class="icnblk_cntnt" id="figlgndparkinsonoverviewF1"><h4 id="parkinson-overview.F1"><a href="/books/NBK1223/figure/parkinson-overview.F1/?report=objectonly" target="object" rid-ob="figobparkinsonoverviewF1">Figure 1. </a></h4><p class="float-caption no_bottom_margin">Parkinson disease: related terms in use in the clinical setting </p></div></div><p>The cardinal histopathologic feature of Parkinson disease is the loss of dopaminergic neurons in the substantia nigra with intracytoplasmic inclusions (alpha-synuclein- containing Lewy bodies) in the remaining intact nigral neurons.</p><p>Onset of Parkinson disease is most commonly around age 60 years but can vary. The following are generally accepted descriptions regarding age of onset:</p><ul><li class="half_rhythm"><div>Juvenile-onset Parkinson disease. Age &#x0003c;20 years</div></li><li class="half_rhythm"><div>Early-onset adult Parkinson disease. Age 20-50 years</div></li><li class="half_rhythm"><div>Late-onset adult Parkinson disease. Age &#x0003e;50 years</div></li></ul><p>Various terms related to Parkinson disease used in the clinical setting are diagrammed in <a class="figpopup" href="/books/NBK1223/figure/parkinson-overview.F1/?report=objectonly" target="object" rid-figpopup="figparkinsonoverviewF1" rid-ob="figobparkinsonoverviewF1">Figure 1</a>. Parkinsonism is the broadest term that refers to any disorder that includes bradykinesia, rigidity, tremor, and imbalance. "Parkinson plus" includes degenerative conditions in which parkinsonism is a major finding, such as multiple system atrophy, progressive supranuclear palsy, and corticobasal degeneration.</p></div></div><div id="parkinson-overview._escape__2_Causes_of"><h2 id="_parkinson-overview__escape__2_Causes_of_">2. Causes of Parkinson Disease</h2><p>Parkinson disease results from complex interplay of non-genetic and genetic factors. However, genetic factors are increasingly recognized as causative.</p><p>Typically Parkinson disease occurs in only one family member (i.e., a <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> case); less commonly it occurs in several family members (i.e., <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> Parkinson disease). Historically, about 15% of individuals with Parkinson disease have a positive family history of PD.</p><p>An estimated 5%-10% of all Parkinson disease is attributed to pathogenic variants in single genes (monogenic Parkinson disease) (<a class="figpopup" href="/books/NBK1223/table/parkinson-overview.T.earlyonset_and_late/?report=objectonly" target="object" rid-figpopup="figparkinsonoverviewTearlyonsetandlate" rid-ob="figobparkinsonoverviewTearlyonsetandlate">Table 1</a>, <a class="figpopup" href="/books/NBK1223/table/parkinson-overview.T.juvenileonset_parki/?report=objectonly" target="object" rid-figpopup="figparkinsonoverviewTjuvenileonsetparki" rid-ob="figobparkinsonoverviewTjuvenileonsetparki">Table 2</a>). In addition to these variants, other genetic and environmental factors &#x02013; known and unknown &#x02013; may contribute to overall risk [<a class="bk_pop" href="#parkinson-overview.REF.kalinderi.2016.314">Kalinderi et al 2016</a>, <a class="bk_pop" href="#parkinson-overview.REF.kim.2017.135">Kim &#x00026; Alcalay 2017</a>].</p><div id="parkinson-overview.Monogenic_Parkinson_D"><h3>Monogenic Parkinson Disease</h3><p>Monogenic Parkinson disease can be inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>, <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>, or, uncommonly, <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> manner. Age of onset in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> can be useful in distinguishing autosomal dominant PD (typically age &#x0003e;50 years) from autosomal recessive PD (typically age &#x0003c;40 years) [<a class="bk_pop" href="#parkinson-overview.REF.kasten.2018.730">Kasten et al 2018</a>]; however, age of onset can vary greatly between individuals with the same genetic variant.</p><p><b>Adult-onset Parkinson disease.</b>
<a class="figpopup" href="/books/NBK1223/table/parkinson-overview.T.earlyonset_and_late/?report=objectonly" target="object" rid-figpopup="figparkinsonoverviewTearlyonsetandlate" rid-ob="figobparkinsonoverviewTearlyonsetandlate">Table 1</a> lists the genes associated with early-onset adult PD (age 20-50 years) and late-onset adult PD (age &#x0003e;50 years). <a class="figpopup" href="/books/NBK1223/table/parkinson-overview.T.earlyonset_and_late/?report=objectonly" target="object" rid-figpopup="figparkinsonoverviewTearlyonsetandlate" rid-ob="figobparkinsonoverviewTearlyonsetandlate">Table 1</a> uses the recommended International Parkinson and Movement Disorder Society Task Force for Nomenclature of Genetic Movement Disorders, in which the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> prefix, PARK, is followed by the italicized <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> symbol (e.g., PARK-<i>LRRK2</i>) [<a class="bk_pop" href="#parkinson-overview.REF.marras.2016.436">Marras et al 2016</a>].</p><div id="parkinson-overview.T.earlyonset_and_late" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Early-Onset and Late-Onset Adult Parkinson Disease: Monogenic Causes</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1223/table/parkinson-overview.T.earlyonset_and_late/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__parkinson-overview.T.earlyonset_and_late_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_parkinson-overview.T.earlyonset_and_late_1_1_1_1" scope="col" rowspan="1" colspan="1" style="background-color:rgb(242,242,242);text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_parkinson-overview.T.earlyonset_and_late_1_1_1_2" scope="col" rowspan="1" colspan="1" style="background-color:rgb(242,242,242);text-align:left;vertical-align:middle;">PD Designation&#x000a0;<sup>2</sup></th><th id="hd_h_parkinson-overview.T.earlyonset_and_late_1_1_1_3" scope="col" rowspan="1" colspan="1" style="background-color:rgb(242,242,242);text-align:left;vertical-align:middle;">MOI</th><th id="hd_h_parkinson-overview.T.earlyonset_and_late_1_1_1_4" scope="col" rowspan="1" colspan="1" style="background-color:rgb(242,242,242);text-align:left;vertical-align:middle;">% of Adult PD</th><th id="hd_h_parkinson-overview.T.earlyonset_and_late_1_1_1_5" scope="col" rowspan="1" colspan="1" style="background-color:rgb(242,242,242);text-align:left;vertical-align:middle;">Comments</th><th id="hd_h_parkinson-overview.T.earlyonset_and_late_1_1_1_6" scope="col" rowspan="1" colspan="1" style="background-color:rgb(242,242,242);text-align:left;vertical-align:middle;"><i>GeneReview</i> or OMIM Entry</th></tr></thead><tbody><tr><td headers="hd_h_parkinson-overview.T.earlyonset_and_late_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>GBA</i>&#x000a0;<sup>3</sup></td><td headers="hd_h_parkinson-overview.T.earlyonset_and_late_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">PARK-<i>GBA</i></td><td headers="hd_h_parkinson-overview.T.earlyonset_and_late_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_parkinson-overview.T.earlyonset_and_late_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">3%-7%<br />(20% in AJ ancestry)</td><td headers="hd_h_parkinson-overview.T.earlyonset_and_late_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Onset age may be &#x0003c;50 yrs.</div></li><li class="half_rhythm"><div>Higher likelihood of cognitive impairment, atypical motor findings &#x00026; severe progression</div></li><li class="half_rhythm"><div>Associated w/dementia w/Lewy bodies</div></li><li class="half_rhythm"><div>Variable <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> dependent on age, variant, &#x00026; ethnicity&#x000a0;<sup>4</sup></div></li><li class="half_rhythm"><div>Consider if family history of <a href="/books/n/gene/gaucher/">Gaucher disease</a>.</div></li></ul>
</td><td headers="hd_h_parkinson-overview.T.earlyonset_and_late_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">OMIM <a href="https://omim.org/entry/606463" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">606463</a></td></tr><tr><td headers="hd_h_parkinson-overview.T.earlyonset_and_late_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>LRRK2</i></td><td headers="hd_h_parkinson-overview.T.earlyonset_and_late_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">PARK-<i>LRRK2</i></td><td headers="hd_h_parkinson-overview.T.earlyonset_and_late_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_parkinson-overview.T.earlyonset_and_late_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1%-2%<br />(13%-30% in AJ ancestry; 41% in African Berber ancestry)</td><td headers="hd_h_parkinson-overview.T.earlyonset_and_late_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Classic manifestations w/less non-motor involvement</div></li><li class="half_rhythm"><div>Variable <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> dependent on age, variant, &#x00026; ethnicity&#x000a0;<sup>5</sup></div></li></ul>
</td><td headers="hd_h_parkinson-overview.T.earlyonset_and_late_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/lrrk2/"><i>LRRK2</i>-Related PD</a></td></tr><tr><td headers="hd_h_parkinson-overview.T.earlyonset_and_late_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PARK7</i><br />(<i>DJ1</i>)</td><td headers="hd_h_parkinson-overview.T.earlyonset_and_late_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">PARK-<i>DJ1</i></td><td headers="hd_h_parkinson-overview.T.earlyonset_and_late_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_parkinson-overview.T.earlyonset_and_late_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Rare</td><td headers="hd_h_parkinson-overview.T.earlyonset_and_late_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Phenotype similar to PARK-<i>Parkin</i></div></li><li class="half_rhythm"><div>ID &#x00026;/or seizures occasionally</div></li><li class="half_rhythm"><div>Risk to heterozygotes unknown</div></li></ul>
</td><td headers="hd_h_parkinson-overview.T.earlyonset_and_late_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">OMIM <a href="https://omim.org/entry/606324" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">606324</a></td></tr><tr><td headers="hd_h_parkinson-overview.T.earlyonset_and_late_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PINK1</i></td><td headers="hd_h_parkinson-overview.T.earlyonset_and_late_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">PARK-<i>PINK1</i></td><td headers="hd_h_parkinson-overview.T.earlyonset_and_late_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_parkinson-overview.T.earlyonset_and_late_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Rare<br />(3.7% of early-onset adult PD)</td><td headers="hd_h_parkinson-overview.T.earlyonset_and_late_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Phenotype similar to PARK-<i>Parkin</i></div></li><li class="half_rhythm"><div>Non-motor manifestations incl psychiatric features more common</div></li><li class="half_rhythm"><div>Heterozygotes may have &#x02191; PD risk.</div></li></ul>
</td><td headers="hd_h_parkinson-overview.T.earlyonset_and_late_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/pink1-pd/"><i>PINK1</i> Type of Young-Onset PD</a></td></tr><tr><td headers="hd_h_parkinson-overview.T.earlyonset_and_late_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PRKN</i></td><td headers="hd_h_parkinson-overview.T.earlyonset_and_late_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">PARK-<i>Parkin</i></td><td headers="hd_h_parkinson-overview.T.earlyonset_and_late_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_parkinson-overview.T.earlyonset_and_late_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1%<br />(4.6%-10.5% of early-onset adult PD)</td><td headers="hd_h_parkinson-overview.T.earlyonset_and_late_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Slow progression</div></li><li class="half_rhythm"><div>Can have lower-limb dystonia, dyskinesias, hyperreflexia</div></li><li class="half_rhythm"><div>Mild non-motor manifestations</div></li><li class="half_rhythm"><div>Heterozygotes may have &#x02191; PD risk.</div></li></ul>
</td><td headers="hd_h_parkinson-overview.T.earlyonset_and_late_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/jpd/">Parkin Type of Early-Onset PD</a></td></tr><tr><td headers="hd_h_parkinson-overview.T.earlyonset_and_late_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SNCA</i></td><td headers="hd_h_parkinson-overview.T.earlyonset_and_late_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">PARK-<i>SNCA</i></td><td headers="hd_h_parkinson-overview.T.earlyonset_and_late_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_parkinson-overview.T.earlyonset_and_late_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Rare</td><td headers="hd_h_parkinson-overview.T.earlyonset_and_late_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Onset age may be &#x0003c;50 yrs</div></li><li class="half_rhythm"><div>Cognitive &#x00026; psychiatric features more likely</div></li></ul>
</td><td headers="hd_h_parkinson-overview.T.earlyonset_and_late_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">OMIM <a href="https://omim.org/entry/168601" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">168601</a>, <a href="https://omim.org/entry/605543" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">605543</a></td></tr><tr><td headers="hd_h_parkinson-overview.T.earlyonset_and_late_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>VPS13C</i></td><td headers="hd_h_parkinson-overview.T.earlyonset_and_late_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Not assigned</td><td headers="hd_h_parkinson-overview.T.earlyonset_and_late_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_parkinson-overview.T.earlyonset_and_late_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Rare</td><td headers="hd_h_parkinson-overview.T.earlyonset_and_late_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Early-onset PD w/very rapid progression; truncating variants cause severe disease.</td><td headers="hd_h_parkinson-overview.T.earlyonset_and_late_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#parkinson-overview.REF.puschmann.2017.66">Puschmann [2017]</a>, <a class="bk_pop" href="#parkinson-overview.REF.reed.2019.230">Reed et al [2019]</a></td></tr><tr><td headers="hd_h_parkinson-overview.T.earlyonset_and_late_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>VPS35</i></td><td headers="hd_h_parkinson-overview.T.earlyonset_and_late_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">PARK-<i>VPS35</i></td><td headers="hd_h_parkinson-overview.T.earlyonset_and_late_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_parkinson-overview.T.earlyonset_and_late_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Rare</td><td headers="hd_h_parkinson-overview.T.earlyonset_and_late_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Classic PD w/tremor</div></li><li class="half_rhythm"><div>Fewer non-motor manifestations</div></li></ul>
</td><td headers="hd_h_parkinson-overview.T.earlyonset_and_late_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/vps35-pd/"><i>VPS35</i>-Related PD</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">AD = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>; AJ = <a class="def" href="/books/n/gene/glossary/def-item/ashkenazi-jewish/">Ashkenazi Jewish</a>; AR = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>; ID = intellectual disability; MOI = <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a>; PD = Parkinson disease</p></div></dd><dt></dt><dd><div><p class="no_margin">See <a href="http://omim.org/phenotypicSeries/PS168600" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Parkinson disease: Phenotypic Series</a> to view genes associated with this <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> in OMIM.</p></div></dd><dt>1. </dt><dd><div id="parkinson-overview.TF.1.1"><p class="no_margin">Genes are listed in alphabetic order.</p></div></dd><dt>2. </dt><dd><div id="parkinson-overview.TF.1.2"><p class="no_margin">Nomenclature based on <a class="bk_pop" href="#parkinson-overview.REF.marras.2016.436">Marras et al [2016]</a></p></div></dd><dt>3. </dt><dd><div id="parkinson-overview.TF.1.3"><p class="no_margin">There is some disagreement among researchers as to whether <i>GBA</i> should be classified as a monogenic disorder or, alternatively, a risk factor &#x02013; due to its low age-related <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a>. However, of note, some <i>GBA</i> variants (including the fairly common Leu444Pro variant) have estimated penetrance approaching that of <i>LRRK2</i> variants [<a class="bk_pop" href="#parkinson-overview.REF.ganor.2015.880">Gan-Or et al 2015</a>, <a class="bk_pop" href="#parkinson-overview.REF.lee.2017.1432">Lee et al 2017</a>].</p></div></dd><dt>4. </dt><dd><div id="parkinson-overview.TF.1.4"><p class="no_margin">The estimated <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> of the c.1226A&#x0003e;G (p.Asn409Ser) <i>GBA</i> variant is 6%-14% for all populations. Higher penetrance is reported for severe <i>GBA</i> variants [<a class="bk_pop" href="#parkinson-overview.REF.ganor.2015.880">Gan-Or et al 2015</a>].</p></div></dd><dt>5. </dt><dd><div id="parkinson-overview.TF.1.5"><p class="no_margin">The estimated <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> of the c.6055G&#x0003e;A (p.Gly2019Ser) <i>LRRK2</i> variant is 25%-43% for all populations [<a class="bk_pop" href="#parkinson-overview.REF.marder.2015.89">Marder et al 2015</a>, <a class="bk_pop" href="#parkinson-overview.REF.lee.2017.1432">Lee et al 2017</a>]. The estimated penetrance for other <i>LRRK2</i> variants may be higher or lower, possibly related to the location of the variant within the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> [<a class="bk_pop" href="#parkinson-overview.REF.trinh.2014">Trinh et al 2014</a>].</p></div></dd></dl></div></div></div><p><b>Juvenile-onset Parkinson disease.</b> Variants in several genes have been associated with juvenile-onset Parkinson disease (i.e., onset age generally &#x0003c;20 years but can vary) (<a class="figpopup" href="/books/NBK1223/table/parkinson-overview.T.juvenileonset_parki/?report=objectonly" target="object" rid-figpopup="figparkinsonoverviewTjuvenileonsetparki" rid-ob="figobparkinsonoverviewTjuvenileonsetparki">Table 2</a>). Inheritance of juvenile-onset PD is usually <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>; the clinical presentation often includes additional signs such as dystonia, spasticity, and dementia.</p><div id="parkinson-overview.T.juvenileonset_parki" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Juvenile-Onset Parkinson Disease: Monogenic Causes</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1223/table/parkinson-overview.T.juvenileonset_parki/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__parkinson-overview.T.juvenileonset_parki_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_parkinson-overview.T.juvenileonset_parki_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_parkinson-overview.T.juvenileonset_parki_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">PD Designation&#x000a0;<sup>2</sup></th><th id="hd_h_parkinson-overview.T.juvenileonset_parki_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">MOI</th><th id="hd_h_parkinson-overview.T.juvenileonset_parki_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">% of Juvenile-Onset PD</th><th id="hd_h_parkinson-overview.T.juvenileonset_parki_1_1_1_5" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Comments</th><th id="hd_h_parkinson-overview.T.juvenileonset_parki_1_1_1_6" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">References</th></tr></thead><tbody><tr><td headers="hd_h_parkinson-overview.T.juvenileonset_parki_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ATP13A2</i></td><td headers="hd_h_parkinson-overview.T.juvenileonset_parki_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">PARK-<i>ATP13A2</i></td><td headers="hd_h_parkinson-overview.T.juvenileonset_parki_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_parkinson-overview.T.juvenileonset_parki_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Rare</td><td headers="hd_h_parkinson-overview.T.juvenileonset_parki_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Triad of spasticity, supranuclear gaze palsy, &#x00026; dementia</div></li><li class="half_rhythm"><div>Wide variability</div></li><li class="half_rhythm"><div>Also referred to as Kufor-Rakeb syndrome or juvenile-onset atypical PD</div></li></ul>
</td><td headers="hd_h_parkinson-overview.T.juvenileonset_parki_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#parkinson-overview.REF.park.2015.770">Park et al [2015]</a>, OMIM <a href="https://omim.org/entry/606693" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">606693</a></td></tr><tr><td headers="hd_h_parkinson-overview.T.juvenileonset_parki_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>DNAJC6</i></td><td headers="hd_h_parkinson-overview.T.juvenileonset_parki_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">PARK-<i>DNAJC6</i></td><td headers="hd_h_parkinson-overview.T.juvenileonset_parki_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_parkinson-overview.T.juvenileonset_parki_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Rare</td><td headers="hd_h_parkinson-overview.T.juvenileonset_parki_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2 subtypes identified:
<ul><li class="half_rhythm"><div>Slowly progressing, levodopa-responsive parkinsonism; onset in 3<sup>rd</sup>-4th decade</div></li><li class="half_rhythm"><div>Rare juvenile onset w/rapid disease progression; atypical features of hyperreflexia, seizures, &#x00026; ID</div></li></ul>
Variants w/milder effect on protein function may cause adult early-onset PD w/few other symptoms.&#x000a0;<sup>3</sup></td><td headers="hd_h_parkinson-overview.T.juvenileonset_parki_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">OMIM <a href="https://omim.org/entry/615528" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">615528</a></td></tr><tr><td headers="hd_h_parkinson-overview.T.juvenileonset_parki_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>FBXO7</i></td><td headers="hd_h_parkinson-overview.T.juvenileonset_parki_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">PARK-<i>FBXO7</i></td><td headers="hd_h_parkinson-overview.T.juvenileonset_parki_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_parkinson-overview.T.juvenileonset_parki_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Rare</td><td headers="hd_h_parkinson-overview.T.juvenileonset_parki_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Juvenile or early-onset adult, rapidly progressive, may have corticospinal signs</div></li><li class="half_rhythm"><div>Early-onset parkinsonism w/bradykinesia in some families</div></li></ul>
</td><td headers="hd_h_parkinson-overview.T.juvenileonset_parki_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">OMIM <a href="https://omim.org/entry/260300" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">260300</a></td></tr><tr><td headers="hd_h_parkinson-overview.T.juvenileonset_parki_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PODXL</i></td><td headers="hd_h_parkinson-overview.T.juvenileonset_parki_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Not assigned</td><td headers="hd_h_parkinson-overview.T.juvenileonset_parki_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_parkinson-overview.T.juvenileonset_parki_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1 family reported</td><td headers="hd_h_parkinson-overview.T.juvenileonset_parki_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Levodopa-responsive PD w/no atypical features&#x000a0;<sup>4</sup></td><td headers="hd_h_parkinson-overview.T.juvenileonset_parki_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#parkinson-overview.REF.puschmann.2017.66">Puschmann [2017]</a></td></tr><tr><td headers="hd_h_parkinson-overview.T.juvenileonset_parki_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SLC6A3</i></td><td headers="hd_h_parkinson-overview.T.juvenileonset_parki_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DYT/PARK-<br /><i>SLC6A3</i></td><td headers="hd_h_parkinson-overview.T.juvenileonset_parki_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_parkinson-overview.T.juvenileonset_parki_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Rare</td><td headers="hd_h_parkinson-overview.T.juvenileonset_parki_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Onset in infancy</div></li><li class="half_rhythm"><div>Also referred to as dopamine transporter deficiency syndrome or infantile parkinsonism-dystonia-1</div></li></ul>
</td><td headers="hd_h_parkinson-overview.T.juvenileonset_parki_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">OMIM <a href="https://omim.org/entry/613135" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">613135</a></td></tr><tr><td headers="hd_h_parkinson-overview.T.juvenileonset_parki_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SYNJ1</i>&#x000a0;<sup>5</sup></td><td headers="hd_h_parkinson-overview.T.juvenileonset_parki_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">PARK-<i>SYNJ1</i></td><td headers="hd_h_parkinson-overview.T.juvenileonset_parki_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_parkinson-overview.T.juvenileonset_parki_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Rare</td><td headers="hd_h_parkinson-overview.T.juvenileonset_parki_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Variants in SAC1-like <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> cause juvenile-onset dystonia w/dyskinesia</div></li><li class="half_rhythm"><div>1 family w/early-onset adult PD reported</div></li></ul>
</td><td headers="hd_h_parkinson-overview.T.juvenileonset_parki_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">OMIM <a href="https://omim.org/entry/617389" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">617389</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">AR = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>; ID = intellectual disability; MOI = <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a>; PD = Parkinson disease</p></div></dd><dt>1. </dt><dd><div id="parkinson-overview.TF.2.1"><p class="no_margin">Genes are listed in alphabetic order.</p></div></dd><dt>2. </dt><dd><div id="parkinson-overview.TF.2.2"><p class="no_margin">Nomenclature based on <a class="bk_pop" href="#parkinson-overview.REF.marras.2016.436">Marras et al [2016]</a></p></div></dd><dt>3. </dt><dd><div id="parkinson-overview.TF.2.3"><p class="no_margin">Variants that are deleterious or have a large effect on protein function may lead to more severe, juvenile-onset <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>, whereas those with a milder effect on protein function may lead to "adult early-onset PD with few or no additional signs and symptoms" [<a class="bk_pop" href="#parkinson-overview.REF.puschmann.2017.66">Puschmann 2017</a>].</p></div></dd><dt>4. </dt><dd><div id="parkinson-overview.TF.2.4"><p class="no_margin">Atypical features are neurologic manifestations including early cognitive decline, severe dystonia, corticospinal signs (hyperreflexia), spasticity, seizures, and oculomotor limitations &#x02013; in addition to the rigidity, tremor, and bradykinesia that characterize PD.</p></div></dd><dt>5. </dt><dd><div id="parkinson-overview.TF.2.5"><p class="no_margin">Allelic disorder: AR epilepsy syndrome [<a class="bk_pop" href="#parkinson-overview.REF.puschmann.2017.66">Puschmann 2017</a>]</p></div></dd></dl></div></div></div><p><b>Other suspected genetic risk factors for Parkinson disease.</b> Evidence that variants in other genes may increase the risk for Parkinson disease is less well supported [<a class="bk_pop" href="#parkinson-overview.REF.kalia.2015.896">Kalia &#x00026; Lang 2015</a>, <a class="bk_pop" href="#parkinson-overview.REF.ruizmartinez.2015.637">Ruiz-Martinez et al 2015</a>, <a class="bk_pop" href="#parkinson-overview.REF.zhang.2015.2073">Zhang et al 2015</a>, <a class="bk_pop" href="#parkinson-overview.REF.lee.2017.733">Lee &#x00026; Hsu 2017</a>, <a class="bk_pop" href="#parkinson-overview.REF.puschmann.2017.66">Puschmann 2017</a>, <a class="bk_pop" href="#parkinson-overview.REF.youn.2019.224.e9">Youn et al 2019</a>]:</p><ul><li class="half_rhythm"><div>Genetic variants reported in single families include <i>RIC3</i>, <i>TMEM230</i>, and <i>UCHL1.</i></div></li><li class="half_rhythm"><div>Evidence is conflicting for <i>EIF4G1</i> and <i>DNAJC13.</i></div></li><li class="half_rhythm"><div>Further confirmation is needed to clarify the risk associated with <i>CHCHD2</i>, <i>GIGYF2,</i> and <i>HTRA2</i>.</div></li></ul><p>Additional studies are needed to confirm and clarify the role of variants in these genes in Parkinson disease causation [<a class="bk_pop" href="#parkinson-overview.REF.kim.2017.135">Kim &#x00026; Alcalay 2017</a>]. While these genes may appear on Parkinson disease multigene testing panels, it is suggested that they not be included in diagnostic testing because of their limited clinical utility (see <a href="#parkinson-overview._escape__3_Evaluation">Evaluation Strategies</a>).</p></div><div id="parkinson-overview.Susceptibility_Genes"><h3>Susceptibility Genes for Parkinson Disease</h3><p>In addition to the major known monogenic causes of Parkinson disease (<a class="figpopup" href="/books/NBK1223/table/parkinson-overview.T.earlyonset_and_late/?report=objectonly" target="object" rid-figpopup="figparkinsonoverviewTearlyonsetandlate" rid-ob="figobparkinsonoverviewTearlyonsetandlate">Table 1</a>, <a class="figpopup" href="/books/NBK1223/table/parkinson-overview.T.juvenileonset_parki/?report=objectonly" target="object" rid-figpopup="figparkinsonoverviewTjuvenileonsetparki" rid-ob="figobparkinsonoverviewTjuvenileonsetparki">Table 2</a>), additional genes and susceptibility loci have been identified through genome-wide association studies (GWAS) and other research. Furthermore, genetic modifiers may influence lifetime risk for PD or clinical aspects of PD such as age of onset and progression of motor and non-motor features [<a class="bk_pop" href="#parkinson-overview.REF.davis.2016.209.e1">Davis et al 2016</a>]. While these genetic modifiers may contribute in small ways to PD risk [<a class="bk_pop" href="#parkinson-overview.REF.reed.2019.230">Reed et al 2019</a>], most are not yet clinically applicable and more research is needed to clarify their role in clinical diagnosis and risk assessment.</p><p>Variants in such susceptibility genes differ from variants in genes known to cause Parkinson disease: no variant in any of the susceptibility genes "causes" PD. Thus, such genes should not be included in diagnostic testing (see <a href="#parkinson-overview._escape__3_Evaluation">Evaluation Strategies</a>).</p></div><div id="parkinson-overview.Environmental_Risk_Fa"><h3>Environmental Risk Factors for Parkinson Disease</h3><p>One of the most important non-genetic factors contributing to Parkinson disease risk is advancing age. Epidemiologic studies have shown possible association of Parkinson disease with environmental factors including pesticide exposure, head injury, rural living, and infectious agents.</p><p>Environmental factors that may be associated with a lower risk for PD include tobacco smoking, caffeine consumption, use of nonsteroidal anti-inflammatory drugs (NSAID), high blood urate levels, and physical activity [<a class="bk_pop" href="#parkinson-overview.REF.kalia.2015.896">Kalia &#x00026; Lang 2015</a>, <a class="bk_pop" href="#parkinson-overview.REF.ascherio.2016.1257">Ascherio &#x00026; Schwarzschild 2016</a>].</p></div></div><div id="parkinson-overview._escape__3_Evaluation"><h2 id="_parkinson-overview__escape__3_Evaluation_">3. Evaluation Strategies to Identify the Genetic Cause of Parkinson Disease in a Proband</h2><p>Establishing a specific genetic cause of Parkinson disease:</p><ul><li class="half_rhythm"><div>Can aid in discussions of causation, recurrence risks, and research eligibility (see <a href="#parkinson-overview._escape__5_Participat">Goal 5</a>).</div></li><li class="half_rhythm"><div>May provide some information about <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> including prognosis of a particular monogenic cause of Parkinson disease (<a class="figpopup" href="/books/NBK1223/table/parkinson-overview.T.earlyonset_and_late/?report=objectonly" target="object" rid-figpopup="figparkinsonoverviewTearlyonsetandlate" rid-ob="figobparkinsonoverviewTearlyonsetandlate">Table 1</a>, <a class="figpopup" href="/books/NBK1223/table/parkinson-overview.T.juvenileonset_parki/?report=objectonly" target="object" rid-figpopup="figparkinsonoverviewTjuvenileonsetparki" rid-ob="figobparkinsonoverviewTjuvenileonsetparki">Table 2</a>).</div></li><li class="half_rhythm"><div>Usually involves evaluation of medical and family histories, and <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>. Physical examination may be less helpful in suggesting a specific genetic cause because of the overlap of clinical features [<a class="bk_pop" href="#parkinson-overview.REF.kasten.2018.730">Kasten et al 2018</a>, <a class="bk_pop" href="#parkinson-overview.REF.trinh.2019.133">Trinh et al 2019</a>].</div></li></ul><p><b>Medical history.</b> Age of onset and age at diagnosis may help distinguish <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> monogenic causes of PD and <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> monogenic causes of PD (<a class="figpopup" href="/books/NBK1223/table/parkinson-overview.T.earlyonset_and_late/?report=objectonly" target="object" rid-figpopup="figparkinsonoverviewTearlyonsetandlate" rid-ob="figobparkinsonoverviewTearlyonsetandlate">Table 1</a>, <a class="figpopup" href="/books/NBK1223/table/parkinson-overview.T.juvenileonset_parki/?report=objectonly" target="object" rid-figpopup="figparkinsonoverviewTjuvenileonsetparki" rid-ob="figobparkinsonoverviewTjuvenileonsetparki">Table 2</a>). History of another related diagnosis or overlapping condition may aid in diagnosis and guide genetic testing. For example, if dystonia is a predominant feature of the condition, this may suggest alternative testing. (See <a href="/books/n/gene/dystonia-ov/">Dystonia Overview</a>.)</p><p><b>Physical and mental examination.</b> Typically, findings on a physical or mental examination will not entirely implicate a monogenic cause of Parkinson disease. However, the presence of certain clinical features can provide clues, such as significant cognitive impairment (<a class="figpopup" href="/books/NBK1223/table/parkinson-overview.T.earlyonset_and_late/?report=objectonly" target="object" rid-figpopup="figparkinsonoverviewTearlyonsetandlate" rid-ob="figobparkinsonoverviewTearlyonsetandlate">Table 1</a>, <a class="figpopup" href="/books/NBK1223/table/parkinson-overview.T.juvenileonset_parki/?report=objectonly" target="object" rid-figpopup="figparkinsonoverviewTjuvenileonsetparki" rid-ob="figobparkinsonoverviewTjuvenileonsetparki">Table 2</a>).</p><p><b>Family history.</b> A three-generation family history should be obtained, with particular attention to any individual with a movement disorder and/or neurodegenerative disorder, with the following also noted:</p><ul><li class="half_rhythm"><div>Age of onset/diagnosis of disease, which may help distinguish <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> from <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> monogenic PD if genetic (<a class="figpopup" href="/books/NBK1223/table/parkinson-overview.T.earlyonset_and_late/?report=objectonly" target="object" rid-figpopup="figparkinsonoverviewTearlyonsetandlate" rid-ob="figobparkinsonoverviewTearlyonsetandlate">Table 1</a>, <a class="figpopup" href="/books/NBK1223/table/parkinson-overview.T.juvenileonset_parki/?report=objectonly" target="object" rid-figpopup="figparkinsonoverviewTjuvenileonsetparki" rid-ob="figobparkinsonoverviewTjuvenileonsetparki">Table 2</a>)</div></li><li class="half_rhythm"><div>Age (or age at death), which will help distinguish unaffected individuals from individuals whose clinical status cannot be determined as they are younger than the typical age of onset for PD</div></li><li class="half_rhythm"><div>Details and results of genetic testing of relatives</div></li><li class="half_rhythm"><div>Ethnicity, as some populations are more likely to have certain causative pathogenic variants (see <a class="figpopup" href="/books/NBK1223/table/parkinson-overview.T.earlyonset_and_late/?report=objectonly" target="object" rid-figpopup="figparkinsonoverviewTearlyonsetandlate" rid-ob="figobparkinsonoverviewTearlyonsetandlate">Table 1</a>)</div></li><li class="half_rhythm"><div>Evaluation by a neurologist (preferably one specializing in movement disorders) of first-degree relatives who have findings concerning for PD</div></li></ul><p><b>Molecular genetic testing</b> approaches can include a combination of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted testing (<a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a> or single-gene testing) and less commonly, comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing (<a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a>, <a class="def" href="/books/n/gene/glossary/def-item/exome-array/">exome array</a>, or genomic sequencing). Gene-targeted testing requires the clinician to hypothesize which gene(s) are likely involved, whereas genomic testing does not.</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> or targeted variant testing.</b> In a family with an established molecular diagnosis of PD (i.e., a PD-related <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member), targeted testing for the <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> variant would be indicated. Gene-targeted testing may be appropriate in other limited circumstances (e.g., a family history of <a href="/books/n/gene/gaucher/">Gaucher disease</a> indicates an increased likelihood of <i>GBA</i> involvement and an African-Berber ancestry indicates a higher likelihood of <i>LRRK2</i> involvement). However, single-gene testing is rarely useful and typically not recommended because of the significant overlap in clinical manifestations and age of onset in PD.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes some or all of the genes listed in <a class="figpopup" href="/books/NBK1223/table/parkinson-overview.T.earlyonset_and_late/?report=objectonly" target="object" rid-figpopup="figparkinsonoverviewTearlyonsetandlate" rid-ob="figobparkinsonoverviewTearlyonsetandlate">Table 1</a> and <a class="figpopup" href="/books/NBK1223/table/parkinson-overview.T.juvenileonset_parki/?report=objectonly" target="object" rid-figpopup="figparkinsonoverviewTjuvenileonsetparki" rid-ob="figobparkinsonoverviewTjuvenileonsetparki">Table 2</a> is most likely to identify a genetic cause of Parkinson disease at the most reasonable cost while limiting identification of variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>. Of note, given the rarity of some of the genes associated with Parkinson disease, some panels may not include all the genes included in <a class="figpopup" href="/books/NBK1223/table/parkinson-overview.T.earlyonset_and_late/?report=objectonly" target="object" rid-figpopup="figparkinsonoverviewTearlyonsetandlate" rid-ob="figobparkinsonoverviewTearlyonsetandlate">Table 1</a> and <a class="figpopup" href="/books/NBK1223/table/parkinson-overview.T.juvenileonset_parki/?report=objectonly" target="object" rid-figpopup="figparkinsonoverviewTjuvenileonsetparki" rid-ob="figobparkinsonoverviewTjuvenileonsetparki">Table 2</a>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</div><div class="half_rhythm">For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</div></li></ul><ul><li class="half_rhythm"><div class="half_rhythm"><b>Comprehensive</b>
<b><a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (which does not require the clinician to determine which <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>[s] are likely involved) may be considered; however, genomic testing in Parkinson disease is still being evaluated, and yield and utility remain to be determined [<a class="bk_pop" href="#parkinson-overview.REF.schormair.2018.603">Schormair et al 2018</a>, <a class="bk_pop" href="#parkinson-overview.REF.trinh.2019.133">Trinh et al 2019</a>].</div><div class="half_rhythm">For an introduction to comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</div></li></ul></div><div id="parkinson-overview._escape__4_Genetic_Co"><h2 id="_parkinson-overview__escape__4_Genetic_Co_">4. Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="parkinson-overview.Typical_LateOnset_Par"><h3>Typical, Late-Onset Parkinson Disease of Unknown Cause</h3><p>Typical, late-onset Parkinson disease of unknown cause is generally presumed to be <a class="def" href="/books/n/gene/glossary/def-item/multifactorial/">multifactorial</a> in origin (i.e., the result of combined contributions of genetic and environmental factors). Recurrence risk counseling for family members of individuals with presumed multifactorial Parkinson disease (often referred to as "<a class="def" href="/books/n/gene/glossary/def-item/idiopathic/">idiopathic</a>" or "<a class="def" href="/books/n/gene/glossary/def-item/sporadic/">sporadic</a>" in the Parkinson disease literature; see Note) and their family members must be empiric and relatively nonspecific. PD is fairly common in the general population and the cumulative lifetime risk (i.e., to age 85 years) of developing PD approaches 4% [<a class="bk_pop" href="#parkinson-overview.REF.tysnes.2017.901">Tysnes &#x00026; Storstein 2017</a>, <a class="bk_pop" href="#parkinson-overview.REF.deng.2018.72">Deng et al 2018</a>, <a class="bk_pop" href="#parkinson-overview.REF.licher.2019.148">Licher et al 2019</a>]. Taking into account family history, the cumulative lifetime risk to first-degree relatives (parents, sibs, and offspring) of an individual with typical, late-onset Parkinson disease of unknown cause who represents a <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> case (i.e., the only <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member) is estimated be about twofold greater (i.e., 8%) [<a class="bk_pop" href="#parkinson-overview.REF.gaare.2017.241">Gaare et al 2017</a>, <a class="bk_pop" href="#parkinson-overview.REF.liu.2018.631">Liu et al 2018</a>].</p><p>Note:&#x000a0;"Idiopathic Parkinson disease" and "<a class="def" href="/books/n/gene/glossary/def-item/sporadic/">sporadic</a> Parkinson disease" are terms used in the Parkinson disease medical literature to describe Parkinson disease of unknown cause diagnosed in an individual with a negative family history. Because future advances in the understanding of genetic risk factors are likely to identify genetic causes/risk factors for some Parkinson disease currently considered "<a class="def" href="/books/n/gene/glossary/def-item/idiopathic/">idiopathic</a>" or "sporadic." these terms are generally not used in this GeneReview. Instead, the term "Parkinson disease of unknown cause representing a <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> case" is preferred because "simplex case" refers specifically to an individual with no family history of Parkinson disease without implying presence or absence of a genetic factor or a specific <a class="def" href="/books/n/gene/glossary/def-item/recurrence-risk/">recurrence risk</a>.</p></div><div id="parkinson-overview.Monogenic_Mendelian_P"><h3>Monogenic (Mendelian) Parkinson Disease</h3><div id="parkinson-overview.Mode_of_Inheritance"><h4>Mode of Inheritance</h4><p>Monogenic Parkinson disease is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>, <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>, or <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> manner. (See <a href="/books/n/gene/xdp/">X-Linked Dystonia-Parkinsonism</a> for a review of X-linked inheritance.)</p></div><div id="parkinson-overview.Risk_to_Family_Member"><h4>Risk to Family Members &#x02013; Autosomal Dominant Inheritance</h4><p>Parkinson disease caused by a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in one of four genes &#x02013; <i>GBA</i>, <i>LRRK2</i>, <i>SNCA</i>, or <i>VPS35</i> &#x02013; is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner (<a class="figpopup" href="/books/NBK1223/table/parkinson-overview.T.earlyonset_and_late/?report=objectonly" target="object" rid-figpopup="figparkinsonoverviewTearlyonsetandlate" rid-ob="figobparkinsonoverviewTearlyonsetandlate">Table 1</a>). This section refers only to families having a known Parkinson disease-causing pathogenic variant in one of these four genes.</p><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>Almost all individuals diagnosed with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> Parkinson disease inherited a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> from a parent, who may or not be <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>.</div></li><li class="half_rhythm"><div>In very rare instances, a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> diagnosed with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> Parkinson disease has the disorder as the result of a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div></li><li class="half_rhythm"><div>If the parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> undergo <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> for the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the proband and the pathogenic variant cannot be detected in the leukocyte DNA of either parent, possible explanations include a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic variant in the proband or the theoretic possibility of <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> in a parent.</div></li><li class="half_rhythm"><div>The family history of some individuals diagnosed with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> Parkinson disease may appear to be negative because of failure to recognize the disorder in family members, early death of the parent before the onset of symptoms, late onset of the disease in the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent, variable expression, or (especially in <i>GBA</i>- and <i>LRRK2-</i>related Parkinson disease) reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a>. Therefore, an apparently negative family history can only be confirmed with parental <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to the sibs of the proband depends on the genetic status of the proband's parents:</p><ul><li class="half_rhythm"><div>If a parent of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is known to have the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> identified in the proband, the risk to each sib of having inherited the variant is 50%. While all sibs who inherit a <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> pathogenic variant will be at increased risk for Parkinson disease, not all <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> sibs will manifest the disease; both reduced, age-related <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> and intrafamilial clinical variability are observed in <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> Parkinson disease.</div></li><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> cannot be detected in the leukocyte DNA of either parent, the <a class="def" href="/books/n/gene/glossary/def-item/recurrence-risk/">recurrence risk</a> to sibs is estimated to be 1% because of the theoretic possibility of parental <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> [<a class="bk_pop" href="#parkinson-overview.REF.rahbari.2016.126">Rahbari et al 2016</a>].</div></li><li class="half_rhythm"><div>If the parents have not been tested for the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> identified in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> but are clinically unaffected, sibs are still presumed to be at increased risk for Parkinson disease because of the possibility of reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> in a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> parent or the theoretic possibility of parental <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>Each child of an individual with an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> Parkinson disease-causing <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has a 50% chance of inheriting the pathogenic variant.</div></li><li class="half_rhythm"><div>The probability that offspring who inherit a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> will manifest Parkinson disease increases with advancing age (see <a class="figpopup" href="/books/NBK1223/table/parkinson-overview.T.earlyonset_and_late/?report=objectonly" target="object" rid-figpopup="figparkinsonoverviewTearlyonsetandlate" rid-ob="figobparkinsonoverviewTearlyonsetandlate">Table 1</a>, <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> footnotes).</div></li></ul></div><div id="parkinson-overview.Risk_to_Family_Member_1"><h4>Risk to Family Members &#x02013; Autosomal Recessive Inheritance</h4><p>Parkinson disease caused by <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>ATP13A2</i>, <i>DJ1</i>, <i>DNAJC6</i>, <i>FBXO7</i>, <i>PINK1</i>, <i>PODXL</i>, <i>PRKN</i>, <i>SLC6A3</i>, <i>SYNJ1</i>, or <i>VPS13C</i> is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner (<a class="figpopup" href="/books/NBK1223/table/parkinson-overview.T.earlyonset_and_late/?report=objectonly" target="object" rid-figpopup="figparkinsonoverviewTearlyonsetandlate" rid-ob="figobparkinsonoverviewTearlyonsetandlate">Table 1</a>, <a class="figpopup" href="/books/NBK1223/table/parkinson-overview.T.juvenileonset_parki/?report=objectonly" target="object" rid-figpopup="figparkinsonoverviewTjuvenileonsetparki" rid-ob="figobparkinsonoverviewTjuvenileonsetparki">Table 2</a>).</p><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The parents of an individual with an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> Parkinson disease are obligate heterozygotes for one Parkinson disease-related <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div></li><li class="half_rhythm"><div>Heterozygotes for a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>DJ1, PINK1</i>, or <i>PRKN</i> (genes typically associated with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> adult-onset Parkinson disease) may be at increased risk for adult-onset Parkinson disease (<a class="figpopup" href="/books/NBK1223/table/parkinson-overview.T.earlyonset_and_late/?report=objectonly" target="object" rid-figpopup="figparkinsonoverviewTearlyonsetandlate" rid-ob="figobparkinsonoverviewTearlyonsetandlate">Table 1</a>) [<a class="bk_pop" href="#parkinson-overview.REF.kim.2017.135">Kim &#x00026; Alcalay 2017</a>, <a class="bk_pop" href="#parkinson-overview.REF.reed.2019.230">Reed et al 2019</a>].</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>At conception, each sib of an individual with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> Parkinson disease has a 25% chance of inheriting both pathogenic variants and being <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, a 50% chance of inheriting one <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> and being <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a>, and a 25% chance of inheriting neither pathogenic variant.</div></li><li class="half_rhythm"><div>Heterozygotes for a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> associated with adult-onset Parkinson disease may be at increased the risk for Parkinson disease (see <a href="#parkinson-overview.Risk_to_Family_Member_1">AR Inheritance</a>, <b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b>).</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The offspring of an individual with an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> Parkinson disease are obligate heterozygotes for a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. Heterozygotes for a pathogenic variant associated with adult-onset Parkinson disease may be at increased the risk of Parkinson disease (see <a href="#parkinson-overview.Risk_to_Family_Member_1">AR Inheritance</a>, <b>Parents of a proband</b>).</p></div><div id="parkinson-overview.Related_Genetic_Couns"><h4>Related Genetic Counseling Issues</h4><p><b>Predictive testing for <i>GBA</i>, <i>LRRK2</i>, <i>SNCA</i>, or <i>VPS35</i>-related adult-onset <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> PD</b>
<b>(i.e., testing of asymptomatic, at-risk individuals)</b></p><ul><li class="half_rhythm"><div>Predictive testing for relatives at risk for <i>GBA</i>, <i>LRRK2</i>, <i>SNCA</i>, or <i>VPS35</i>-related adult-onset <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> Parkinson disease is an option once the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member. However, age of onset cannot be accurately predicted by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> because current data suggest that <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> is both age-related and reduced.</div></li><li class="half_rhythm"><div>The following should be discussed in the context of formal <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> prior to testing:</div><ul><li class="half_rhythm"><div>Potential consequences of predictive testing (including but not limited to socioeconomic changes and the need for long-term follow up and evaluation arrangements for individuals with a positive test result)</div></li><li class="half_rhythm"><div>The capabilities and limitations of predictive testing.</div></li></ul></li></ul><p><b>Predictive testing in minors (i.e., testing of asymptomatic at-risk individuals age &#x0003c;18 years)</b></p><ul><li class="half_rhythm"><div>For asymptomatic minors at risk for adult-onset conditions for which early treatment would have no beneficial effect on disease morbidity and mortality, predictive genetic testing is considered inappropriate, primarily because it negates the autonomy of the child with no compelling benefit. Further, concern exists regarding the potential unhealthy adverse effects that such information may have on family dynamics, the risk of discrimination and stigmatization in the future, and the anxiety that such information may cause.</div></li><li class="half_rhythm"><div>For more information, see the National Society of Genetic Counselors <a href="http://www.nsgc.org/p/bl/et/blogaid=860" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">position statement</a> on genetic testing of minors for adult-onset conditions and the American Academy of Pediatrics and American College of Medical Genetics and Genomics <a href="http://pediatrics.aappublications.org/content/131/3/620.full.pdf" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">policy statement</a>: ethical and policy issues in genetic testing and screening of children.</div></li></ul><p>Note: In a family with an established diagnosis of monogenic Parkinson disease, it is appropriate to consider testing of symptomatic individuals regardless of age.</p><p><b>Direct to consumer (DTC</b>) testing is increasingly available. Among the benefits of DTC testing:</p><ul><li class="half_rhythm"><div>It provides easy, quick, and affordable genetic testing for some Parkinson disease-associated variants; and</div></li><li class="half_rhythm"><div>The results of DTC are not inserted into the medical record except when requested by the patient.</div></li></ul><p>On the downside, DTC testing does <b>not</b> provide:</p><ul><li class="half_rhythm"><div>Pretest <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a>;</div></li><li class="half_rhythm"><div>Personalized interpretation of results by a qualified professional; or</div></li><li class="half_rhythm"><div>Supportive counseling to ensure that after disclosure of new health information, the emotional needs of the patient are identified and a plan is made to address them.</div></li></ul><p>For more information, see <a href="https://ghr.nlm.nih.gov/primer/dtcgenetictesting/dtcrisksbenefits" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Genetics Home Reference: What are the benefits and risks of direct-to-consumer genetic testing</a>?</p></div></div></div><div id="parkinson-overview._escape__5_Participat"><h2 id="_parkinson-overview__escape__5_Participat_">5. Participation in Targeted Therapeutic Clinical Trials</h2><p>Several <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted therapies for Parkinson disease are currently in development [<a class="bk_pop" href="#parkinson-overview.REF.sardi.2018.684">Sardi et al 2018</a>]. Individuals may be candidates for a given Parkinson disease clinical trial if they undergo <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> and a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the gene under study is identified.</p><p>Clinical trials for individuals with Parkinson disease and <i>GBA</i> or <i>LRRK2</i> pathogenic variants are now ongoing (<a href="http://www.clinicaltrials.gov" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.clinicaltrials.gov</a>). Testing for common <i>GBA</i> or <i>LRRK2</i> variants is available through DTC testing or, more formally, through a health care professional. See <i>GeneReviews</i>
<a href="/books/n/gene/dtc_testing/">Resources for Genetics Professionals</a> for an overview of DTC testing.</p></div><div id="parkinson-overview.Resources"><h2 id="_parkinson-overview_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>American Parkinson Disease Association (APDA)</b></div><div>135 Parkinson Avenue</div><div>Staten Island NY 10305</div><div><b>Phone:</b> 800-223-2732 (toll-free); 718-981-8001</div><div><b>Fax:</b> 718-981-4399</div><div><b>Email:</b> apda@apdaparkinson.org</div><div><a href="http://www.apdaparkinson.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.apdaparkinson.org</a></div></li><li class="half_rhythm"><div><b>Fox Trial Finder</b></div><div><a href="https://foxtrialfinder.michaeljfox.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">foxtrialfinder.michaeljfox.org/</a></div></li><li class="half_rhythm"><div><b>Medline Plus</b></div><div><a href="https://medlineplus.gov/parkinsonsdisease.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Parkinson's Disease</a></div></li><li class="half_rhythm"><div><b>Michael J. Fox Foundation for Parkinson's Research</b></div><div>Church Street Station</div><div>PO Box 780</div><div>New York NY 10008-0780</div><div><b>Phone:</b> 800-708-7644 (toll-free)</div><div><b>Email:</b> info@michaeljfox.org</div><div><a href="http://www.michaeljfox.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.michaeljfox.org</a></div></li><li class="half_rhythm"><div><b>My46 Trait Profile</b></div><div><a href="https://www.my46.org/trait-document?trait=Parkinson%27s%20disease&#x00026;parent=Disease%20Risk&#x00026;type=profile" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Parkinson Disease</a></div></li><li class="half_rhythm"><div><b>National Institute of Neurological Disorders and Stroke (NINDS)</b></div><div><a href="https://www.ninds.nih.gov/Disorders/All-Disorders/Parkinsons-Disease-Information-Page" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Parkinson's Disease Information Page</a></div></li><li class="half_rhythm"><div><b>National Library of Medicine Genetics Home Reference</b></div><div><a href="http://ghr.nlm.nih.gov/condition=parkinsondisease" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Parkinson disease</a></div></li><li class="half_rhythm"><div><b>Parkinson&#x02019;s Disease Society (UK)</b></div><div>United Kingdom</div><div><b>Phone:</b> 0808 800 0303</div><div><b>Email:</b> hello@parkinsons.org.uk</div><div><a href="https://www.parkinsons.org.uk/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.parkinsons.org.uk</a></div></li><li class="half_rhythm"><div><b>Parkinson's Foundation</b></div><div>200 SE 1st Street</div><div>Suite 800</div><div>Miami FL 33131</div><div><b>Phone:</b> 800-4PD-INFO (473-4636)</div><div><b>Email:</b> contact@parkinson.org</div><div><a href="http://www.parkinson.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.parkinson.org</a></div></li></ul></div><div id="parkinson-overview.References"><h2 id="_parkinson-overview_References_">References</h2><div id="parkinson-overview.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="parkinson-overview.REF.ascherio.2016.1257">Ascherio A, Schwarzschild MA. The epidemiology of Parkinson's disease: risk factors and prevention. <span><span class="ref-journal">Lancet Neurol. </span>2016;<span class="ref-vol">15</span>:1257–72.</span> [<a href="/pubmed/27751556" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27751556</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="parkinson-overview.REF.ba.2015.87">Ba F, Martin WRW. Dopamine transporter imaging as a diagnostic tool for parkinsonism and related disorders in clinical practice. <span><span class="ref-journal">Parkinsonism Relat Disord. </span>2015;<span class="ref-vol">21</span>:87–94.</span> [<a href="/pubmed/25487733" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25487733</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="parkinson-overview.REF.davis.2016.209.e1">Davis AA, Andruska KM, Benitez BA, Racette BA, Perlmutter JS, Cruchaga C. Variants in GBA, SNCA, and MAPT influence Parkinson disease risk, age at onset, and progression. <span><span class="ref-journal">Neurobiol Aging. </span>2016;<span class="ref-vol">37</span>:209.e1–e7.</span> [<a href="/pmc/articles/PMC4688052/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4688052</span></a>] [<a href="/pubmed/26601739" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26601739</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="parkinson-overview.REF.deng.2018.72">Deng H, Wang P, Jankovic J. The genetics of Parkinson disease. <span><span class="ref-journal">Ageing Res Rev. </span>2018;<span class="ref-vol">42</span>:72–85.</span> [<a href="/pubmed/29288112" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29288112</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="parkinson-overview.REF.gaare.2017.241">Gaare JJ, Skeie GO, Tzoulis C, Larsen JP, Tysnes OB. Familial aggregation of Parkinson&#x02019;s disease may affect progression of motor symptoms and dementia. <span><span class="ref-journal">Mov Disord. </span>2017;<span class="ref-vol">32</span>:241–5.</span> [<a href="/pubmed/27862270" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27862270</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="parkinson-overview.REF.ganor.2015.880">Gan-Or Z, Amshalom I, Kilarski LL, Bar-Shira A, Gana-Weisz M, Mirelman A, Marder K, Bressman S, Giladi N, Orr-Urtreger A. Differential effects of severe vs mild GBA mutations on Parkinson disease. <span><span class="ref-journal">Neurology. </span>2015;<span class="ref-vol">84</span>:880–7.</span> [<a href="/pmc/articles/PMC4351661/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4351661</span></a>] [<a href="/pubmed/25653295" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25653295</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="parkinson-overview.REF.ibrahim.2016.102">Ibrahim N, Kusmirek J, Struck A, Floberg JM, Perlman SB, Gallagher C, Hall LT. The sensitivity and specificity of F-DOPA PET in a movement disorder clinic. <span><span class="ref-journal">Am J Nucl Med Mol Imaging. </span>2016;<span class="ref-vol">6</span>:102–9.</span> [<a href="/pmc/articles/PMC4749509/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4749509</span></a>] [<a href="/pubmed/27069770" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27069770</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="parkinson-overview.REF.kalia.2015.896">Kalia LV, Lang AE. Parkinson&#x02019;s disease. <span><span class="ref-journal">Lancet. </span>2015;<span class="ref-vol">386</span>:896–912.</span> [<a href="/pubmed/25904081" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25904081</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="parkinson-overview.REF.kalinderi.2016.314">Kalinderi K, Bostantjopoulou S, Fidani L. The genetic background of Parkinson&#x02019;s disease: current progress and future prospects. <span><span class="ref-journal">Acta Neurol Scand. </span>2016;<span class="ref-vol">134</span>:314–26.</span> [<a href="/pubmed/26869347" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26869347</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="parkinson-overview.REF.kasten.2018.730">Kasten M, Hartmann C, Hampf J, Schaake S, Westenberger A, Vollstedt EJ, Balck A, Domingo A, Vulinovic F, Dulovic M, Zorn I, Madoev H, Zehnle H, Lembeck CM, Schawe L, Reginold J, Huang J, K&#x000f6;nig IR, Bertram L, Marras C, Lohmann K, Lill CM, Klein C. Genotype-phenotype relations for the Parkinson's disease genes Parkin, PINK1, DJ1: MDSGene Systematic Review. <span><span class="ref-journal">Mov Disord. </span>2018;<span class="ref-vol">33</span>:730–41.</span> [<a href="/pubmed/29644727" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29644727</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="parkinson-overview.REF.kim.2017.135">Kim CY, Alcalay RN. Genetic forms of Parkinson&#x02019;s disease. <span><span class="ref-journal">Semin Neurol. </span>2017;<span class="ref-vol">37</span>:135–46.</span> [<a href="/pubmed/28511254" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28511254</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="parkinson-overview.REF.lee.2017.1432">Lee AJ, Wang Y, Alcalay RN, Mejia-Santana H, Saunders-Pullman R, Bressman S, Corvol JC, Brice A, Lesage S, Mangone G, Tolosa E, Pont-Sunyer C, Vilas D, Sch&#x000fc;le B, Kausar F, Foroud T, Berg D, Brockmann K, Goldwurm S, Siri C, Asselta R, Ruiz-Martinez J, Mondrag&#x000f3;n E, Marras C, Ghate T, Giladi N, Mirelman A, Marder K, Michael J., Fox LRRK2 Cohort Consortium.  Penetrance estimate of LRRK2 p.G2019S mutation in individuals of non-Ashkenazi Jewish ancestry. <span><span class="ref-journal">Mov Disord. </span>2017;<span class="ref-vol">32</span>:1432–8.</span> [<a href="/pmc/articles/PMC5656509/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5656509</span></a>] [<a href="/pubmed/28639421" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28639421</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="parkinson-overview.REF.lee.2017.733">Lee YC, Hsu SD. Familial mutations and post-translational modifications of UCH-L1 in Parkinson's disease and neurodegenerative disorders. <span><span class="ref-journal">Curr Protein Pept Sci. </span>2017;<span class="ref-vol">18</span>:733–45.</span> [<a href="/pubmed/26899237" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26899237</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="parkinson-overview.REF.licher.2019.148">Licher S, Darweesh SKL, Wolters FJ, Fani L, Heshmatollah A, Mutlu U, Koudstaal PJ, Heeringa J, Leening MJG, Ikram MK, Ikram MA. Lifetime risk of common neurological diseases in the elderly population. <span><span class="ref-journal">J Neurol Neurosurg Psychiatry. </span>2019;<span class="ref-vol">90</span>:148–56.</span> [<a href="/pubmed/30279211" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 30279211</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="parkinson-overview.REF.liu.2018.631">Liu FC, Lin HT, Kuo CF, Hsieh MY, See LC, Yu HP. Familial aggregation of Parkinson's disease and coaggregation with neuropsychiatric diseases: a population-based cohort study. <span><span class="ref-journal">Clin Epidemiol. </span>2018;<span class="ref-vol">10</span>:631–41.</span> [<a href="/pmc/articles/PMC5985793/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5985793</span></a>] [<a href="/pubmed/29881310" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29881310</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="parkinson-overview.REF.marder.2015.89">Marder K, Wang Y, Alcalay RN, Mejia-Santana H, Tang MX, Lee A, Raymond D, Mirelman A, Saunders-Pullman R, Clark L, Ozelius L, Orr-Urtreger A, Giladi N, Bressman S, et al.  Age-specific penetrance of LRRK2 G2019S in the Michael J. Fox Ashkenazi Jewish LRRK2 Consortium. <span><span class="ref-journal">Neurology. </span>2015;<span class="ref-vol">85</span>:89–95.</span> [<a href="/pmc/articles/PMC4501942/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4501942</span></a>] [<a href="/pubmed/26062626" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26062626</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="parkinson-overview.REF.marras.2016.436">Marras C, Lang A, van de Warrenburg BP, Sue CM, Tabrizi SJ, Bertram L, Mercimek-Mahmutoglu S, Ebrahimi-Fakhari D, Warner TT, Durr A, Assmann B, Lohmann K, Kostic V, Klein C. Nomenclature of genetic movement disorders: recommendations of the International Parkinson and Movement Disorder Society task force. <span><span class="ref-journal">Mov Disord. </span>2016;<span class="ref-vol">31</span>:436–57.</span> [<a href="/pubmed/27079681" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27079681</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="parkinson-overview.REF.park.2015.770">Park J-S, Blair NF, Sue CM. The role of ATP13A2 in Parkinson&#x02019;s disease: Clinical phenotypes and molecular mechanisms. <span><span class="ref-journal">Mov Disord. </span>2015;<span class="ref-vol">30</span>:770–9.</span> [<a href="/pubmed/25900096" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25900096</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="parkinson-overview.REF.postuma.2015.1591">Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, Obeso J, Marek K, Litvan I, Lang AE, Halliday G, Goetz CG, Gasser T, Dubois B, Chan P, Bloem BR, Adler CH, Deuschl G. MDS clinical diagnostic criteria for Parkinson's disease. <span><span class="ref-journal">Mov Disord. </span>2015;<span class="ref-vol">30</span>:1591–601.</span> [<a href="/pubmed/26474316" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26474316</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="parkinson-overview.REF.postuma.2018.1601">Postuma RB, Poewe W, Litvan I, Lewis S, Lang AE, Halliday G, Goetz CG, Chan P, Slow E, Seppi K, Schaffer E, Rios-Romenets S, Mi T, Maetzler C, Li Y, Heim B, Bledsoe IO, Berg D. Validation of the MDS clinical diagnostic criteria for Parkinson's disease. <span><span class="ref-journal">Mov Disord. </span>2018;<span class="ref-vol">33</span>:1601–8.</span> [<a href="/pubmed/30145797" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 30145797</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="parkinson-overview.REF.puschmann.2017.66">Puschmann A. New genes causing hereditary Parkinson&#x02019;s disease or parkinsonism. <span><span class="ref-journal">Curr Neurol Neurosci Rep. </span>2017;<span class="ref-vol">17</span>:66.</span> [<a href="/pmc/articles/PMC5522513/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5522513</span></a>] [<a href="/pubmed/28733970" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28733970</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="parkinson-overview.REF.rahbari.2016.126">Rahbari R, Wuster A, Lindsay SJ, Hardwick RJ, Alexandrov LB, Turki SA, Dominiczak A, Morris A, Porteous D, Smith B, Stratton MR, Hurles ME, et al.  Timing, rates, and spectra of human germline mutation. <span><span class="ref-journal">Nat Genet. </span>2016;<span class="ref-vol">48</span>:126–33.</span> [<a href="/pmc/articles/PMC4731925/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4731925</span></a>] [<a href="/pubmed/26656846" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26656846</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="parkinson-overview.REF.reed.2019.230">Reed X, Bandr&#x000e9;s-Ciga S, Blauwendraat C, Cookson MR. The role of monogenic genes in idiopathic Parkinson&#x02019;s disease. <span><span class="ref-journal">Neurobiol Dis. </span>2019;<span class="ref-vol">124</span>:230–9.</span> [<a href="/pmc/articles/PMC6363864/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC6363864</span></a>] [<a href="/pubmed/30448284" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 30448284</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="parkinson-overview.REF.ruizmartinez.2015.637">Ruiz-Martinez J, Krebs CE, Makarov V, Gorostidi A, Mart&#x000ed;-Mass&#x000f3; JF, Pais&#x000e1;n-Ruiz C. GIGYF2 mutation in late-onset Parkinson&#x02019;s disease with cognitive impairment. <span><span class="ref-journal">J Hum Genet. </span>2015;<span class="ref-vol">60</span>:637–40.</span> [<a href="/pmc/articles/PMC4624020/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4624020</span></a>] [<a href="/pubmed/26134514" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26134514</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="parkinson-overview.REF.sardi.2018.684">Sardi SP, Cedarbaum JM, Brundin P. Targeted therapies for Parkinson's disease: from genetics to the clinic. <span><span class="ref-journal">Mov Disord. </span>2018;<span class="ref-vol">33</span>:684–96.</span> [<a href="/pmc/articles/PMC6282975/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC6282975</span></a>] [<a href="/pubmed/29704272" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29704272</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="parkinson-overview.REF.schormair.2018.603">Schormair B, Kemlink D, Mollenhauer B, Fiala O, Machetanz G, Roth J, Berutti R, Strom TM, Haslinger B, Trenkwalder C, Zahorakova D, Martasek P, Ruzicka E, Winkelmann J. Diagnostic exome sequencing in early-onset Parkinson's disease confirms VPS13C as a rare cause of autosomal-recessive Parkinson's disease. <span><span class="ref-journal">Clin Genet. </span>2018;<span class="ref-vol">93</span>:603–12.</span> [<a href="/pubmed/28862745" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28862745</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="parkinson-overview.REF.trinh.2014">Trinh J, Guelle I, Farrer MJ. Disease penetrance of late-onset parkinsonism: a meta-analysis. 2014;71:1535-9. [<a href="/pubmed/25330418" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25330418</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="parkinson-overview.REF.trinh.2019.133">Trinh J, Lohmann K, Baumann H, Balck A, Borsche M, Br&#x000fc;ggemann N, Dure L, Dean M, Volkmann J, Tunc S, Prasuhn J, Pawlack H, Imhoff S, Lill CM, Kasten M, Bauer P, Rolfs A. International Parkinson's Disease Genomics Consortium (IPDGC), Klein C. Utility and implications of exome sequencing in early-onset Parkinson's disease. <span><span class="ref-journal">Mov Disord. </span>2019;<span class="ref-vol">34</span>:133–7.</span> [<a href="/pubmed/30537300" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 30537300</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="parkinson-overview.REF.tysnes.2017.901">Tysnes OB, Storstein A. Epidemiology of Parkinson&#x02019;s disease. <span><span class="ref-journal">J Neural Transm (Vienna). </span>2017;<span class="ref-vol">124</span>:901–5.</span> [<a href="/pubmed/28150045" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28150045</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="parkinson-overview.REF.youn.2019.224.e9">Youn J, Lee C, Oh E, Park J, Kim JS, Kim HT, Cho JW, Park WY, Jang W, Ki CS. Genetic variants of PARK genes in Korean patients with early-onset Parkinson&#x02019;s disease. <span><span class="ref-journal">Neurobiol Aging. </span>2019;<span class="ref-vol">75</span>:224.e9–224.e15.</span> [<a href="/pubmed/30502028" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 30502028</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="parkinson-overview.REF.zhang.2015.2073">Zhang Y, Sun Q-Y, Yu R-H, Guo J-F, Tang B-S, Yan X-X. The contribution of GIGYF2 to Parkinson&#x02019;s disease: a meta-analysis. <span><span class="ref-journal">Neurol Sci. </span>2015;<span class="ref-vol">36</span>:2073–9.</span> [<a href="/pubmed/26152800" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26152800</span></a>]</div></li></ul></div></div><div id="parkinson-overview.Chapter_Notes"><h2 id="_parkinson-overview_Chapter_Notes_">Chapter Notes</h2><div id="parkinson-overview.Author_History"><h3>Author History</h3><p>Lola Cook Shukla, MS (2019-present)<br />Janice Farlow, BS, BA (2014-present)<br />Tatiana Foroud, PhD (2004-present)<br />Nathan D Pankratz, PhD (2004-present)<br />Jeanine Schulze, MS (2019-present)<br />Joanne Wojcieszek, MD (2004-present)</p></div><div id="parkinson-overview.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>25 July 2019 (bp) Comprehensive update posted live</div></li><li class="half_rhythm"><div>27 February 2014 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>9 July 2009 (cd) Revision: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> symbol <i>DJ-1</i> replaced by <i>PARK7</i> according to HGNC (gene nomenclature standard for GeneTests)</div></li><li class="half_rhythm"><div>2 October 2007 (cd) Revision: clinical testing (<a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>) available for <i>SNCA</i>-related Parkinson disease</div></li><li class="half_rhythm"><div>5 February 2007 (cd) Revision: prenatal testing available for <i>PARK2</i> and <i>LRRK2</i> mutations</div></li><li class="half_rhythm"><div>16 October 2006 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>9 January 2006 (cd) Revision: testing for <i>LRRK2</i> clinically available</div></li><li class="half_rhythm"><div>11 March 2005 (cd) Revision: <i>LRRK2</i> identified as causative <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> for PARK8</div></li><li class="half_rhythm"><div>25 May 2004 (me) Overview posted live</div></li><li class="half_rhythm"><div>12 November 2003 (tmf) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1223</span><span class="label">PMID: <a href="/pubmed/20301402" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301402</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/jpd/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/pmld1/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1223&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1223/?report=reader">PubReader</a></li><li><a href="/books/NBK1223/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1223" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1223" style="display:none" title="Cite this Page"><div class="bk_tt">Cook Shukla L, Schulze J, Farlow J, et al. Parkinson Disease Overview. 2004 May 25 [Updated 2019 Jul 25]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1223/pdf/Bookshelf_NBK1223.pdf">PDF version of this page</a> (578K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#parkinson-overview.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#parkinson-overview._escape__1_Clinical_C" ref="log$=inpage&amp;link_id=inpage">1. Clinical Characteristics of Parkinson Disease</a></li><li><a href="#parkinson-overview._escape__2_Causes_of" ref="log$=inpage&amp;link_id=inpage">2. Causes of Parkinson Disease</a></li><li><a href="#parkinson-overview._escape__3_Evaluation" ref="log$=inpage&amp;link_id=inpage">3. Evaluation Strategies to Identify the Genetic Cause of Parkinson Disease in a Proband</a></li><li><a href="#parkinson-overview._escape__4_Genetic_Co" ref="log$=inpage&amp;link_id=inpage">4. Genetic Counseling</a></li><li><a href="#parkinson-overview._escape__5_Participat" ref="log$=inpage&amp;link_id=inpage">5. Participation in Targeted Therapeutic Clinical Trials</a></li><li><a href="#parkinson-overview.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#parkinson-overview.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#parkinson-overview.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=5071[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">PRKN</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=65018[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">PINK1</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=6908[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">TBP</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=2747[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">GLUD2</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=120892[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">LRRK2</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=6315[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">ATXN8OS</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=2629[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">GBA</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=26058[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">GIGYF2</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=11315[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">PARK7</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=55737[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">VPS35</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=23400[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">ATP13A2</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=6622[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">SNCA</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=126[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">ADH1C</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=6311[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">ATXN2</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=25793[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">FBXO7</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=4576[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">MT-TT</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=4929[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">NR4A2</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=8398[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">PLA2G6</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=9627[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">SNCAIP</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=27429[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">HTRA2</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=4137[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">MAPT</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=7345[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">UCHL1</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1478104" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1478104" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301334" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Hereditary Dystonia Overview</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Hereditary Dystonia Overview<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Klein C, Lohmann K, Marras C, Münchau A. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20506312" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation update.</a><span class="source">[Hum Mutat. 2010]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation update.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Nuytemans K, Theuns J, Cruts M, Van Broeckhoven C. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Hum Mutat. 2010 Jul; 31(7):763-80. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/29325612" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Genetics of Parkinson disease.</a><span class="source">[Handb Clin Neurol. 2018]</span><div class="brieflinkpop offscreen_noflow">Genetics of Parkinson disease.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Domingo A, Klein C. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Handb Clin Neurol. 2018; 147:211-227. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/30245141" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> The genetic landscape of Parkinson's disease.</a><span class="source">[Rev Neurol (Paris). 2018]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> The genetic landscape of Parkinson's disease.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Lunati A, Lesage S, Brice A. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Rev Neurol (Paris). 2018 Nov; 174(9):628-643. Epub 2018 Sep 21.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/30945962" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedarticles&amp;logdbfrom=pubmed">LRRK2 mutations impair depolarization-induced mitophagy through inhibition of mitochondrial accumulation of RAB10.</a><span class="source">[Autophagy. 2019]</span><div class="brieflinkpop offscreen_noflow">LRRK2 mutations impair depolarization-induced mitophagy through inhibition of mitochondrial accumulation of RAB10.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Wauters F, Cornelissen T, Imberechts D, Martin S, Koentjoro B, Sue C, Vangheluwe P, Vandenberghe W. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Autophagy. 2019 Apr 4; :1-20. Epub 2019 Apr 4.</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301402" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301402" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e041a2bdde08911695d3aa3">Parkinson Disease Overview - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Parkinson Disease Overview - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T21:25:47-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal102&amp;ncbi_phid=CE89A312E0412E910000000003AC01BB&amp;ncbi_session=CE89A312E041A2B1_0940SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1223%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1223&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1223/&amp;ncbi_pagename=Parkinson Disease Overview - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE89A312E041A2B1_0940SID /projects/books/PBooks@5.22 portal102 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>